344 filings
8-K
ACER
Acer Therapeutics Inc.
20 Nov 23
Completion of Acquisition or Disposition of Assets
4:26pm
8-K
ACER
Acer Therapeutics Inc.
8 Nov 23
Submission of Matters to a Vote of Security Holders
4:11pm
8-K
ACER
Acer Therapeutics Inc.
2 Nov 23
Entry into a Material Definitive Agreement
8:49am
8-K
ACER
Acer Therapeutics Inc.
31 Aug 23
Voting and Support Agreement
9:26am
8-K
ACER
Acer Therapeutics Inc.
14 Aug 23
Acer Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
4:09pm
8-K
60t5vkf7b5yz
26 Jun 23
Entry into a Material Definitive Agreement
9:00am
8-K
9swqkq8g 637uy0
7 Jun 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:02pm
8-K
yeirb7tcr 6ia
22 May 23
Submission of Matters to a Vote of Security Holders
4:16pm
8-K
2m1iwsr 9lh9pc
15 May 23
Acer Therapeutics Reports Q1 2023 Financial Results and Provides Corporate Update
5:10pm
8-K
aloviq8umtlkhyolbbvz
3 May 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:33pm
8-K
lhbxcq0ilaqvkj
1 May 23
Acer Therapeutics Announces OLPRUVAâ„¢ Commercial Launch Progressing Ahead of Schedule
9:00am
8-K
5gobd9y glf2ox
27 Apr 23
Other Events
6:06am
8-K
4ai3li37upwm2pnl
27 Mar 23
Acer Therapeutics Reports Q4 and Full Year 2022 Financial Results and Provides Corporate Update
4:03pm
8-K
rnwz5v
22 Mar 23
Acer Therapeutics Announces $2.675 Million Registered Direct Offering
4:01pm
8-K
4vd na7ihto
17 Mar 23
Acer Therapeutics Announces Topline Results from ACER-801 (Osanetant) Phase 2a Trial
9:00am
8-K
8qjv6vqrpdvyz05x7le8
15 Mar 23
Other Events
9:00am
8-K
qrlv0woa 24h
13 Feb 23
Topline trial results expected mid-March 2023
9:00am
8-K
uooqvq
7 Feb 23
Other Events
4:01pm
8-K
t4mngag2u8pz
1 Feb 23
Regulation FD Disclosure
4:03pm
8-K
sd2ay23p149dc01eeu
31 Jan 23
Entry into a Material Definitive Agreement
9:25am